Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by US Bancorp DE

US Bancorp DE decreased its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 11.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,088 shares of the company’s stock after selling 398 shares during the period. US Bancorp DE’s holdings in Addus HomeCare were worth $387,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Quarry LP acquired a new position in Addus HomeCare in the third quarter worth approximately $28,000. Farther Finance Advisors LLC lifted its stake in shares of Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after acquiring an additional 148 shares during the last quarter. KBC Group NV increased its holdings in shares of Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock worth $102,000 after purchasing an additional 268 shares during the period. Finally, Assetmark Inc. increased its holdings in shares of Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock worth $156,000 after purchasing an additional 121 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of analyst reports. JMP Securities started coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. Macquarie restated an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Stephens reissued an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $132.78.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $93.09 on Thursday. The firm has a 50-day moving average of $117.30 and a 200-day moving average of $124.04. The stock has a market cap of $1.69 billion, a PE ratio of 21.30, a P/E/G ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a 52-week low of $87.88 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. As a group, analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.